Cervical spondylotic myelopathy patients with prior cerebral infarction: Clinical characteristics, surgical outcomes and prognostic value of "prior cerebral infarction".

[1]  B. Davies,et al.  Degenerative cervical myelopathy , 2018, British Medical Journal.

[2]  Vaner Koksal,et al.  Controversies in the differential diagnosis of Brown-Sequard syndrome due to cervical spinal disease from stroke: A case series , 2017, Turkish journal of emergency medicine.

[3]  U. Ahn,et al.  The Influence of Diabetes on Surgical Outcomes in Cervical Myelopathy , 2016, Spine.

[4]  H. van Loveren,et al.  Blood-Spinal Cord Barrier Alterations in Subacute and Chronic Stages of a Rat Model of Focal Cerebral Ischemia , 2016, Journal of neuropathology and experimental neurology.

[5]  J. Zeng,et al.  Dynamic secondary degeneration in the spinal cord and ventral root after a focal cerebral infarction among hypertensive rats , 2016, Scientific Reports.

[6]  M. Fehlings,et al.  Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis , 2015, Spine.

[7]  M. Fehlings,et al.  Pathobiology of cervical spondylotic myelopathy , 2015, European Spine Journal.

[8]  Yoshiaki Toyama,et al.  Risk factors for development of myelopathy in patients with cervical spondylotic cord compression , 2015, European Spine Journal.

[9]  M. Fehlings,et al.  Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review , 2015, European Spine Journal.

[10]  Y. Yukawa,et al.  Risk factors for poor outcome of cervical laminoplasty for cervical spondylotic myelopathy in patients with diabetes. , 2014, The Journal of bone and joint surgery. American volume.

[11]  T. Ueta,et al.  Rapid progressive clinical deterioration of cervical spondylotic myelopathy , 2014, Spinal Cord.

[12]  M. Fehlings,et al.  Predictors of outcome in patients with cervical spondylotic myelopathy undergoing surgical treatment: a survey of members from AOSpine International. , 2014, World neurosurgery.

[13]  Y. Yukawa,et al.  Impact of Diabetes on the Outcomes of Cervical Laminoplasty: A Prospective Cohort Study of More Than 500 Patients With Cervical Spondylotic Myelopathy , 2014, Spine.

[14]  M. Fehlings,et al.  Pathophysiology and Natural History of Cervical Spondylotic Myelopathy , 2013, Spine.

[15]  M. Fehlings,et al.  A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study. , 2013, The Journal of bone and joint surgery. American volume.

[16]  G. Yoshida,et al.  The effects of surgery on locomotion in elderly patients with cervical spondylotic myelopathy , 2013, European Spine Journal.

[17]  M. Fehlings,et al.  Cervical Spondylotic Myelopathy , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[18]  M. Fehlings,et al.  A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research , 2013, Neurobiology of Disease.

[19]  K. Ueki,et al.  Altered Blood Flow Distribution in the Rat Spinal Cord under Chronic Compression , 2011, Spine.

[20]  T. Kiehl,et al.  Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy. , 2011, Brain : a journal of neurology.

[21]  Y. Cho,et al.  Intramedullary high signal intensity and neurological status as prognostic factors in cervical spondylotic myelopathy , 2010, Acta Neurochirurgica.

[22]  M. Fehlings,et al.  Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: Implications for the pathophysiology of human cervical spondylotic myelopathy , 2009, Neurobiology of Disease.

[23]  Michael G Fehlings,et al.  Pathophysiology of cervical myelopathy. , 2006, The spine journal : official journal of the North American Spine Society.

[24]  J. Moossy,et al.  Multimodal assessment after surgery for cervical spondylotic myelopathy. , 2005, Journal of neurosurgery. Spine.

[25]  A. Suri,et al.  Effect of intramedullary signal changes on the surgical outcome of patients with cervical spondylotic myelopathy. , 2002, The spine journal : official journal of the North American Spine Society.

[26]  L. Noble,et al.  Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events , 2002, The Journal of Neuroscience.

[27]  K. Kaneda,et al.  Correlation between histopathologic features and magnetic resonance images of spinal cord lesions. , 1993, Spine.

[28]  A. Vedantam,et al.  Does the type of T2-weighted hyperintensity influence surgical outcome in patients with cervical spondylotic myelopathy? A review , 2012, European Spine Journal.

[29]  Y. Horiuchi,et al.  Long-term surgical outcome and risk factors in patients with cervical myelopathy and a change in signal intensity of intramedullary spinal cord on Magnetic Resonance imaging. , 2010, Journal of neurosurgery. Spine.

[30]  V. Urbano,et al.  Cervical spondylotic myelopathy due to chronic compression: the role of signal intensity changes in magnetic resonance images. , 2007, Journal of neurosurgery. Spine.